- Home
- CARV vs ACXP Comparison
CARV vs ACXP Comparison
Compare CARV & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CARV
- ACXP
- Stock Information
- Founded
- CARV 1948
- ACXP 2017
- Country
- CARV United States
- ACXP United States
- Employees
- CARV N/A
- ACXP N/A
- Industry
- CARV Savings Institutions
- ACXP Biotechnology: Pharmaceutical Preparations
- Sector
- CARV Finance
- ACXP Health Care
- Exchange
- CARV Nasdaq
- ACXP Nasdaq
- Market Cap
- CARV 7.3M
- ACXP 8.4M
- IPO Year
- CARV 1994
- ACXP 2021
- Fundamental
- Price
- CARV $1.51
- ACXP $0.39
- Analyst Decision
- CARV
- ACXP Strong Buy
- Analyst Count
- CARV 0
- ACXP 2
- Target Price
- CARV N/A
- ACXP $10.00
- AVG Volume (30 Days)
- CARV 21.8K
- ACXP 207.1K
- Earning Date
- CARV 07-15-2025
- ACXP 05-13-2025
- Dividend Yield
- CARV N/A
- ACXP N/A
- EPS Growth
- CARV N/A
- ACXP N/A
- EPS
- CARV N/A
- ACXP N/A
- Revenue
- CARV $24,056,000.00
- ACXP N/A
- Revenue This Year
- CARV N/A
- ACXP N/A
- Revenue Next Year
- CARV N/A
- ACXP N/A
- P/E Ratio
- CARV N/A
- ACXP N/A
- Revenue Growth
- CARV N/A
- ACXP N/A
- 52 Week Low
- CARV $1.30
- ACXP $0.30
- 52 Week High
- CARV $2.39
- ACXP $3.33
- Technical
- Relative Strength Index (RSI)
- CARV 57.40
- ACXP 48.09
- Support Level
- CARV $1.35
- ACXP $0.39
- Resistance Level
- CARV $1.52
- ACXP $0.42
- Average True Range (ATR)
- CARV 0.09
- ACXP 0.03
- MACD
- CARV 0.01
- ACXP 0.00
- Stochastic Oscillator
- CARV 84.00
- ACXP 30.75
About CARV Carver Bancorp Inc.
Carver Bancorp Inc is a holding company and conducts its business as a unitary saving and loan holding firm and the business of the company consists of the operation of its subsidiary. The bank offers a wide range of financial solutions to meet customers' banking. It offers other consumer and commercial banking products and services, such as debit cards, online banking, online bill pay, and telephone banking. The company provides deposit products, such as demand, savings, and time deposits for consumers, businesses, and governmental and quasi-governmental agencies in its market area within New York City.
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.